Company Filing History:
Years Active: 2020-2024
Title: Honghu Li: Innovator in Pharmaceutical Chemistry
Introduction
Honghu Li is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing new compounds and methods for medical applications.
Latest Patents
Honghu Li's latest patents include a composition of aminopyran derivative. This invention relates to a composition of a compound of general formula (A), a pharmaceutically acceptable salt, or a prodrug, along with a preparation method for the same. Another significant patent is the use of a GABAA receptor reinforcing agent in the preparation of sedative and anesthetic medicaments. This disclosure provides a pharmaceutical preparation of a compound of formula (I) or a stereoisomer, pharmaceutically acceptable salt, or prodrug thereof. It also outlines a method for general anesthesia or sedation for mammals, along with kits and manufactured products of the medicament and the pharmaceutical composition.
Career Highlights
Throughout his career, Honghu Li has worked with prominent companies in the pharmaceutical industry. He has been associated with Haisco Pharmaceutical Group Co., Ltd. and Haisco Chengdu Pharmaceutical Technology Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Honghu Li has collaborated with several professionals in his field, including Yi Mo and Xing Wan. These collaborations have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Honghu Li is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to advancing medical science and improving therapeutic options. His contributions continue to impact the field positively.